Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2618914rdf:typepubmed:Citationlld:pubmed
pubmed-article:2618914lifeskim:mentionsumls-concept:C0021311lld:lifeskim
pubmed-article:2618914lifeskim:mentionsumls-concept:C0042066lld:lifeskim
pubmed-article:2618914lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:2618914lifeskim:mentionsumls-concept:C0085501lld:lifeskim
pubmed-article:2618914lifeskim:mentionsumls-concept:C0028902lld:lifeskim
pubmed-article:2618914lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:2618914pubmed:issue12lld:pubmed
pubmed-article:2618914pubmed:dateCreated1990-3-14lld:pubmed
pubmed-article:2618914pubmed:abstractTextOfloxacin was administered to 26 males infected with Ureaplasma urealyticum. The infection was confirmed by urine or semen culture. Ofloxacin, administered at daily dose of 300-600 mg for 7 to 28 days, eradicated U. urealyticum in 25 of 26 patients (92.2%).lld:pubmed
pubmed-article:2618914pubmed:languageenglld:pubmed
pubmed-article:2618914pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2618914pubmed:citationSubsetIMlld:pubmed
pubmed-article:2618914pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2618914pubmed:statusMEDLINElld:pubmed
pubmed-article:2618914pubmed:monthDeclld:pubmed
pubmed-article:2618914pubmed:issn0018-1994lld:pubmed
pubmed-article:2618914pubmed:authorpubmed-author:TanakaMMlld:pubmed
pubmed-article:2618914pubmed:authorpubmed-author:NakajimaNNlld:pubmed
pubmed-article:2618914pubmed:authorpubmed-author:KawamuraNNlld:pubmed
pubmed-article:2618914pubmed:authorpubmed-author:HoshinoHHlld:pubmed
pubmed-article:2618914pubmed:authorpubmed-author:KoinumaAAlld:pubmed
pubmed-article:2618914pubmed:issnTypePrintlld:pubmed
pubmed-article:2618914pubmed:volume35lld:pubmed
pubmed-article:2618914pubmed:ownerNLMlld:pubmed
pubmed-article:2618914pubmed:authorsCompleteYlld:pubmed
pubmed-article:2618914pubmed:pagination2149-53lld:pubmed
pubmed-article:2618914pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:2618914pubmed:meshHeadingpubmed-meshheading:2618914-...lld:pubmed
pubmed-article:2618914pubmed:meshHeadingpubmed-meshheading:2618914-...lld:pubmed
pubmed-article:2618914pubmed:meshHeadingpubmed-meshheading:2618914-...lld:pubmed
pubmed-article:2618914pubmed:meshHeadingpubmed-meshheading:2618914-...lld:pubmed
pubmed-article:2618914pubmed:meshHeadingpubmed-meshheading:2618914-...lld:pubmed
pubmed-article:2618914pubmed:meshHeadingpubmed-meshheading:2618914-...lld:pubmed
pubmed-article:2618914pubmed:meshHeadingpubmed-meshheading:2618914-...lld:pubmed
pubmed-article:2618914pubmed:year1989lld:pubmed
pubmed-article:2618914pubmed:articleTitleEffect of ofloxacin in the treatment of genitourinary tract infection with Ureaplasma urealyticum.lld:pubmed
pubmed-article:2618914pubmed:affiliationDepartment of Urology, School of Medicine, Tokai University.lld:pubmed
pubmed-article:2618914pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2618914lld:pubmed